INTERVENTIONS FOR VALVULAR DISEASE AND HEART FAILURE
Matched comparison of next- and early-generation balloon-expandable transcatheter heart valve implantations in failed surgical aortic bioprostheses
EuroIntervention 2018;14:e397-e404 published online April 2018 published online e-edition July 2018. DOI: 10.4244/EIJ-D-17-00546
Moritz Seiffert1, MD; Hendrik Treede2, MD; Joachim Schofer3, MD; Axel Linke4, MD; Jochen Wöhrle5, MD; Hardy Baumbach6, MD; Julinda Mehilli7, MD; Vinayak Bapat8, MD; Matheus Simonato9; Thomas Walther10, MD; Mathias Kullmer11, MD; Peter Boekstegers12, MD; Stephan Ensminger13, MD; Thomas Kurz14, MD; Helene Eltchaninoff15, MD; Ardawan Rastan16, MD; Nicolas Werner17, MD; Arend de Weger18, MD; Christian Frerker19, MD; Bernward Lauer
1. University Heart Center Hamburg, Hamburg, and DZHK (German Center for Cardiovascular Research), partner site Hamburg/Kiel/Lübeck, Hamburg, Germany; 2. University Hospital Halle, Halle (Saale), Germany; 3. Albertinen Heart and Vascular Center, Hamburg,
Aims: Transcatheter valve-in-valve implantation (VinV) is established for the treatment of degenerated surgical bioprostheses in patients at high operative risk. Our aim was to report on
